These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8836822)

  • 21. The aerobic activity of metronidazole against anaerobic bacteria.
    Dione N; Khelaifia S; Lagier JC; Raoult D
    Int J Antimicrob Agents; 2015 May; 45(5):537-40. PubMed ID: 25813393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.
    Edmiston CE; Krepel CJ; Kehl KS; Seabrook GR; Somberg LB; Almassi GH; Smith TL; Loehrl TA; Brown KR; Lewis BD; Towne JB
    J Antimicrob Chemother; 2005 Nov; 56(5):872-8. PubMed ID: 16186167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro activity of spiramycin and metronidazole alone or in combination against clinical isolates from odontogenic abscesses.
    Roche Y; Yoshimori RN
    J Antimicrob Chemother; 1997 Sep; 40(3):353-7. PubMed ID: 9338486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activities of tizoxanide and nitazoxanide compared to those of five other thiazolides and three other agents against anaerobic species.
    Pankuch GA; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1112-7. PubMed ID: 16495282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. False resistance to metronidazole of anaerobic bacteria using the E test.
    Palmer J; Chen S; Gottlieb T; Schio F; Gilbert G
    J Antimicrob Chemother; 1994 Oct; 34(4):598-600. PubMed ID: 7868413
    [No Abstract]   [Full Text] [Related]  

  • 26. Additive or synergistic antimicrobial effects of amoxicillin and metronidazole on whole plaque samples: a preliminary report.
    Walter C; Kulik EM; Weiger R; Zitzmann NU; Waltimo T
    J Int Acad Periodontol; 2011 Jan; 13(1):11-6. PubMed ID: 21387982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence and resistance rates to antibiotics in anaerobic bacteria in specimens from patients with chronic balanitis.
    Boyanova L; Mitev A; Gergova G; Mateev G; Mitov I
    Anaerobe; 2012 Aug; 18(4):414-6. PubMed ID: 22710106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial susceptibility of anaerobic bacteria in Auckland 1987-90.
    Henderson G; Garner J; Morris A
    N Z Med J; 1992 Jan; 105(926):11-2. PubMed ID: 1549266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High rate of non-susceptibility to metronidazole and clindamycin in anaerobic isolates: Data from a clinical laboratory from Karachi, Pakistan.
    Sheikh SO; Jabeen K; Qaiser S; Ahsan ST; Khan E; Zafar A
    Anaerobe; 2015 Jun; 33():132-6. PubMed ID: 25800668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility testing methods: why use the MIC?
    Silley P
    J Antimicrob Chemother; 1991 Jul; 28(1):144-5. PubMed ID: 1769934
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of environmental factors on the in vitro efficacy of ciprofloxacin against anaerobic bacteria.
    Thadepalli H; Bansal MB; Marshall R; Prabhala RH
    Chemotherapy; 1989; 35(3):153-9. PubMed ID: 2766855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of BAY y 3118, and nine other antimicrobial agents against anaerobic bacteria.
    García-Rodríguez JA; García-Sánchez JE; Trujillano-Martín I; García-Sánchez E; García-García MI; Fresnadillo-Martínez MJ
    J Chemother; 1995 Jun; 7(3):189-96. PubMed ID: 7562012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility of anaerobic bacteria to metronidazole. A bacteriological and clinical study.
    Gubina M; Rakovec S; Schoss-Vidensek Z
    Drugs Exp Clin Res; 1985; 11(11):761-4. PubMed ID: 3836860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro activity of a combination of amoxicillin-clavulanic acid on anaerobic bacteria].
    Sedallian A; Roudon T
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):678-81. PubMed ID: 3054746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of activities of trovafloxacin (CP-99,219) and five other agents against 585 anaerobes with use of three media.
    Hecht DW; Osmolski JR
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S44-50. PubMed ID: 8953106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
    Goldstein EJ; Citron DM; Cherubin CE; Hillier SL
    J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. False resistance to metronidazole by E-test among anaerobic bacteria investigations of contributing test conditions and medium quality.
    Cormican MG; Erwin ME; Jones RN
    Diagn Microbiol Infect Dis; 1996 Feb; 24(2):117-9. PubMed ID: 9147908
    [No Abstract]   [Full Text] [Related]  

  • 38. Metronidazole is still the drug of choice for treatment of anaerobic infections.
    Löfmark S; Edlund C; Nord CE
    Clin Infect Dis; 2010 Jan; 50 Suppl 1():S16-23. PubMed ID: 20067388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of buccoadhesive metronidazole tablets: microbiological response.
    Ahuja A; Khar RK; Chaudhry R
    Pharmazie; 1998 Apr; 53(4):264-7. PubMed ID: 9583086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
    Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
    Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.